IDEX Biometrics ASA (OSL:IDEX) 5-Year EBITDA Growth Rate: 53.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:IDEX IDEX Biometrics ASA OSL:IDEX
20 GF Score
Price kr8.46
GF Value kr0.52
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IDEX Biometrics ASA 5-Year EBITDA Growth Rate?

IDEX Biometrics ASA OSL:IDEX +3.93% 20 5-Year EBITDA Growth Rate is 53.50% as of Mar. 2026. GuruFocus rates OSL:IDEX with a GF Score™ of 20/100 and a GF Value™ of kr0.52 (Significantly Overvalued). The stock has 5 warning signs investors should review.

IDEX Biometrics ASA's EBITDA per Share for the three months ended in Mar. 2026 was kr-0.38.

During the past 3 years, the average EBITDA Per Share Growth Rate was 81.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 53.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of IDEX Biometrics ASA was 81.60% per year. The lowest was -58.90% per year. And the median was 0.40% per year.


IDEX Biometrics ASA  (OSL:IDEX) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


IDEX Biometrics ASA 5-Year EBITDA Growth Rate Related Terms


OSL:IDEX vs QH, SHOP, UBER: 5-Year EBITDA Growth Rate Comparison

For the Software - Application subindustry, IDEX Biometrics ASA's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEX Biometrics ASA 5-Year EBITDA Growth Rate vs Software Industry

For the Software industry and Technology sector, IDEX Biometrics ASA's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where IDEX Biometrics ASA's 5-Year EBITDA Growth Rate falls into.


OSL:IDEX
20GF Score
IDEX Biometrics ASA OSL:IDEX
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEX Biometrics ASA 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 53.50% mean?
IDEX Biometrics ASA (OSL:IDEX) has a 5-Year EBITDA Growth Rate of 53.50% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for IDEX Biometrics ASA and its competitors.
Is IDEX Biometrics ASA's 5-Year EBITDA Growth Rate too high?
IDEX Biometrics ASA's current 5-Year EBITDA Growth Rate is 53.50%. Overall, IDEX Biometrics ASA has a GF Score™ of 20/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's 5-Year EBITDA Growth Rate compare to QH and SHOP?
IDEX Biometrics ASA's 5-Year EBITDA Growth Rate of 53.50% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Software company?
A good 5-Year EBITDA Growth Rate depends on the Software industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for IDEX Biometrics ASA and its competitors. IDEX Biometrics ASA's current 5-Year EBITDA Growth Rate is 53.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (OSL:IDEX) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.52, compared to a current price of kr8.46 — trading 1526.9% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 53.50%. IDEX Biometrics ASA's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For IDEX Biometrics ASA (OSL:IDEX), the current 5-Year EBITDA Growth Rate is 53.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEX Biometrics ASA (OSL:IDEX) Overvalued in 2026?

Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued. The current stock price of kr8.46 is trading 1526.9% above its estimated GF Value™ of kr0.52. GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.

Key valuation signals for OSL:IDEX:

  • 5-Year EBITDA Growth Rate: 53.50%
  • GF Value™: kr0.52 vs. price of kr8.46 (1526.9% above fair value)
  • GF Score™: 20/100 with 5 warning signs

No single metric tells the full story. See the OSL:IDEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDEX Biometrics ASA Business Description

Other Exchanges IDXAF:USA0MTP:UKI8X:Germany
Address Henrik Ibsens gate 90, Oslo, NOR, 0255
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
20GF Score

Get the complete analysis for OSL:IDEX

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.46
Price
kr0.52
GF Value